Zevra Therapeutics, Inc. (ZVRA:NASDAQ) closed at $9.81 on October 23, 2026, down 5.03% on the day. The stock trades 34.8% below its 52-week high of $15.04 and 22.5% above its 52-week low of $8.01. Over the past year, it lost 7.5%. Zevra Therapeutics, Inc. is part of the Health Care sector.
In 252 trading sessions since October 23, 2025, ZVRA closed higher on 122 days (48%). Its best day was March 10, 2026 (+21.27%) and its worst was July 24, 2026 (-23.92%). The stock moved 10% or more in a single session 5 times. It opened at least 5% above the previous day's high 2 times.
KemPharm Inc is a clinical-stage specialty pharmaceutical company engaged in the discovery and development of treatments for the central nervous system, CNS, and rare disease indications. The company uses its Ligand Activated Therapy (LAT) platform technology to create prodrugs. Its LAT platform technology discovers and develops prodrugs that improve one or more of the attributes of approved drugs, such as susceptibility to abuse, bioavailability, and safety.
Find more stocks like ZVRA with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.